Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto Simonsson

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Plos One|May 13, 2024
Mindfulness meditation use in Britain during the COVID-19 pandemicOtto Simonsson, Stephen D Fisher
Journal of Psychoactive Drugs|January 10, 2022
Linkages between Psychedelics and Meditation in a Population-Based Sample in the United StatesOtto Simonsson, Simon B Goldberg
Psychedelic Medicine (New Rochelle, N.Y.)|January 5, 2026
The Promises and Pitfalls of Psychedelic Use Among Religious LeadersOtto Simonsson, Simon B Goldberg
International Journal of Environmental Research and Public Health|September 23, 2022
Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based SampleChristin Mellner, Micael Dahlen, Otto Simonsson
Plos One|December 16, 2022
Man's best friend(s): Effects of a brief befriending meditation on human-animal relationsOtto Simonsson, Simon B Goldberg, Walter Osika
Journal of Psychopharmacology (Oxford, England)|March 15, 2021
Associations between lifetime classic psychedelic use and markers of physical healthOtto Simonsson, James D Sexton, Peter S Hendricks
Journal of Psychopharmacology (Oxford, England)|October 30, 2024
Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapiesOtto Simonsson, Simon B Goldberg, Peter S Hendricks
JAMA Health Forum|November 8, 2024
Psychedelic and MDMA-Related Adverse Effects-A Call for ActionOtto Simonsson, Matthew W Johnson, Peter S Hendricks
Journal of Psychopharmacology (Oxford, England)|March 12, 2025
Lifetime classic psychedelic use and headaches: A cross-sectional studyZusanna Bjurenfalk, Alva Cosmo, Otto Simonsson, et al.
Journal of Psychopharmacology (Oxford, England)|October 3, 2022
Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sampleGrant Jones, Jocelyn A Ricard, Peter Hendricks, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Plos One|May 13, 2024
Mindfulness meditation use in Britain during the COVID-19 pandemicOtto Simonsson, Stephen D Fisher
Journal of Psychoactive Drugs|January 10, 2022
Linkages between Psychedelics and Meditation in a Population-Based Sample in the United StatesOtto Simonsson, Simon B Goldberg
Psychedelic Medicine (New Rochelle, N.Y.)|January 5, 2026
The Promises and Pitfalls of Psychedelic Use Among Religious LeadersOtto Simonsson, Simon B Goldberg
International Journal of Environmental Research and Public Health|September 23, 2022
Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based SampleChristin Mellner, Micael Dahlen, Otto Simonsson
Plos One|December 16, 2022
Man's best friend(s): Effects of a brief befriending meditation on human-animal relationsOtto Simonsson, Simon B Goldberg, Walter Osika
Journal of Psychopharmacology (Oxford, England)|March 15, 2021
Associations between lifetime classic psychedelic use and markers of physical healthOtto Simonsson, James D Sexton, Peter S Hendricks
Journal of Psychopharmacology (Oxford, England)|October 30, 2024
Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapiesOtto Simonsson, Simon B Goldberg, Peter S Hendricks
JAMA Health Forum|November 8, 2024
Psychedelic and MDMA-Related Adverse Effects-A Call for ActionOtto Simonsson, Matthew W Johnson, Peter S Hendricks
Journal of Psychopharmacology (Oxford, England)|March 12, 2025
Lifetime classic psychedelic use and headaches: A cross-sectional studyZusanna Bjurenfalk, Alva Cosmo, Otto Simonsson, et al.
Journal of Psychopharmacology (Oxford, England)|October 3, 2022
Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sampleGrant Jones, Jocelyn A Ricard, Peter Hendricks, et al.
Pageof 6